These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2691808)

  • 41. Multi-clinic cross-over comparison of triazolam (Halcion) and placebo in the treatment of co-existing insomnia and anxiety in anxious out-patients.
    Fabre LF; Smith WT
    Dis Nerv Syst; 1977 Jun; 38(6):487-91. PubMed ID: 16735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triazolam treatment of insomnia in depressed patients taking tricyclics.
    Cohn JB
    J Clin Psychiatry; 1983 Nov; 44(11):401-6. PubMed ID: 6139364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind trial of triazolam 0.5 mg vs. nitrazepam 5 mg in outpatients.
    Ellingsen PA
    Acta Psychiatr Scand; 1983 Mar; 67(3):154-8. PubMed ID: 6134429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
    J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of nitrazepam 5 mg with triazolam 0.5 mg in young psychiatric insomniac inpatients. Double-blind single night cross-over study.
    Blumenthal M; Byring R; Koivula K
    Acta Psychiatr Scand; 1980 Nov; 62(5):519-24. PubMed ID: 6111178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    Kales A; Scharf MB; Kales JD; Soldatos CR
    JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical study of quazepam in hospitalized patients with insomnia.
    Uhthoff HK; Brunet JA; Aggerwal A; Varin R
    J Int Med Res; 1981; 9(4):288-91. PubMed ID: 6114885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of nitrazepam with triazolam in insomniac outpatients.
    Dahl LE; Dencker SJ; Lundin L; Kullingsjö H
    Acta Psychiatr Scand; 1982 Feb; 65(2):86-92. PubMed ID: 6138924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
    Dement WC
    J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.
    Pakes GE; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Aug; 22(2):81-110. PubMed ID: 6114852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative study of zopiclone and triazolam in patients with insomnia.
    Chaudoir PJ; Bodkin NL; O'Donnell J; Anderson A; Holland RL
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():21-7. PubMed ID: 2201727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature.
    Rothschild AJ
    J Clin Psychiatry; 1992 Dec; 53 Suppl():69-79. PubMed ID: 1487483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early morning insomnia and daytime anxiety--a multicentre general practice study comparing loprazolam and triazolam.
    Moon CA; Ankier SI; Hayes G
    Br J Clin Pract; 1985 Sep; 39(9):352-8. PubMed ID: 2865963
    [No Abstract]   [Full Text] [Related]  

  • 56. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
    Mendels J
    J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot open-label study of triazolam in the treatment of insomnia following alcohol withdrawal.
    Fabre LF; Gainey A; Kemple S; McLendon DM; Metzler CM
    J Stud Alcohol; 1977 Nov; 38(11):2188-92. PubMed ID: 22780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology and hypnotic efficacy of triazolam.
    Roth T; Roehrs TA; Zorick FJ
    Pharmacotherapy; 1983; 3(3):137-48. PubMed ID: 6136026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Triazolam in the treatment of presurgical patients].
    Venuti A; Saitta FP; Gioffrè Micali M; Giorgianni G; Micali B
    Minerva Chir; 1980 Jun; 35(12):961-4. PubMed ID: 6109267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.